Patents by Inventor Claude P. Genain

Claude P. Genain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibiting MOG-antibody binding
    Patent number: 6573236
    Abstract: The invention provides methods and compositions for inhibiting pathogenic binding of an pathogenic autoantibody to a myelin oligodendrocyte glycoprotein (MOG) autoantigen and screening for inhibitors of pathogenic binding of an autoantibody to a MOG autoantigen.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: June 3, 2003
    Assignee: The Regents of the University of California
    Inventors: Claude P. Genain, Stephen L. Hauser
  • Recombinant antibody fragments as autoantibody antagonists
    Patent number: 6569431
    Abstract: The invention provides methods and compositions for inhibiting autoantibody binding in demyelinating disease such as multiple sclerosis. The compositions comprise immunoglobulin CDR3 sequences derived from combinatorial phage display libraries selected for high-affinity binding to myelin oligodendrocyte glycoprotein.
    Type: Grant
    Filed: July 5, 2001
    Date of Patent: May 27, 2003
    Assignee: The Regents of the University of California
    Inventors: Hans-Christian von Büdingen, Claude P. Genain, Stephen L. Hauser
  • Recombinant antibody fragments as autoantibody antagonists
    Publication number: 20020072588
    Abstract: The invention provides methods and compositions for inhibiting autoantibody binding in demyelinating disease such as multiple sclerosis. The compositions comprise immunoglobulin CDR3 sequences derived from combinatorial phage display libraries selected for high-affinity binding to myelin oligodendrocyte glycoprotein.
    Type: Application
    Filed: July 5, 2001
    Publication date: June 13, 2002
    Inventors: Hans-Christian von Budingen, Claude P. Genain, Stephen L. Hauser
  • Autoantibody inhibitors
    Publication number: 20020068058
    Abstract: The invention provides methods and compositions for inhibiting pathogenic binding of an pathogenic autoantibody to a myelin oligodendrocyte glycoprotein (MOG) autoantigen and screening for inhibitors of pathogenic binding of an autoantibody to a MOG autoantigen.
    Type: Application
    Filed: December 21, 2001
    Publication date: June 6, 2002
    Inventors: Claude P. Genain, Stephen L. Hauser
  • Autoantibody inhibitors
    Patent number: 6333033
    Abstract: The invention provides methods and compositions for inhibiting pathogenic binding of an pathogenic autoantibody to a myelin oligodendrocyte glycoprotein (MOG) autoantigen and screening for inhibitors of pathogenic binding of an autoantibody to a MOG autoantigen.
    Type: Grant
    Filed: August 26, 1999
    Date of Patent: December 25, 2001
    Assignee: The Regents of the University of California
    Inventors: Claude P. Genain, Stephen L. Hauser